rs730882150
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015634.4(KIFBP):c.599C>A(p.Ser200*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000746 in 1,608,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000077 ( 0 hom. )
Consequence
KIFBP
NM_015634.4 stop_gained
NM_015634.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 4.10
Genes affected
KIFBP (HGNC:23419): (kinesin family binding protein) This gene encodes a kinesin family member 1 binding protein that is characterized by two tetratrico peptide repeats. The encoded protein localizes to the mitochondria and may be involved in regulating transport of the mitochondria. Mutations in this gene are associated with Goldberg-Shprintzen megacolon syndrome. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-69005119-C-A is Pathogenic according to our data. Variant chr10-69005119-C-A is described in ClinVar as [Pathogenic]. Clinvar id is 183145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIFBP | NM_015634.4 | c.599C>A | p.Ser200* | stop_gained | 3/7 | ENST00000361983.7 | NP_056449.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIFBP | ENST00000361983.7 | c.599C>A | p.Ser200* | stop_gained | 3/7 | 1 | NM_015634.4 | ENSP00000354848.4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152054Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
8
AN:
152054
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251244Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135826
GnomAD3 exomes
AF:
AC:
8
AN:
251244
Hom.:
AF XY:
AC XY:
2
AN XY:
135826
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000769 AC: 112AN: 1456070Hom.: 0 Cov.: 28 AF XY: 0.0000635 AC XY: 46AN XY: 724784
GnomAD4 exome
AF:
AC:
112
AN:
1456070
Hom.:
Cov.:
28
AF XY:
AC XY:
46
AN XY:
724784
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152054Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74278
GnomAD4 genome
AF:
AC:
8
AN:
152054
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74278
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
3
ExAC
AF:
AC:
3
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Goldberg-Shprintzen syndrome Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This nonsense variant found in exon 3 of 7 is predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a homozygous change in two siblings with Goldberg-Shprintzen syndrome (GOSHS) (PMID: 23427148). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.003% (9/282480) and thus is presumed to be rare. Based on the available evidence, the c.599C>A (p.Ser200Ter) variant is classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 08, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 15, 2013 | - - |
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Mar 13, 2024 | The heterozygous p.Ser200Ter variant in KIFBP was identified by our study, in the compound heterozygous state with a likely pathogenic variant (ClinVar ID: 300283), in two siblings with congenital fibrosis of the extraocular muscles, hearing impairment, developmental delays, cognitive impairment, scoliosis, Hirschsprung disease, and dysmorphic facial features, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Engle lab (https://kirbyneuro.org/EngleLab/). Familial genome analysis revealed that this variant was in trans with a likely pathogenic variant (ClinVar Variation ID: 300283). We believe this is a possible phenotype expansion for Goldberg-Shprintzen megacolon syndrome. The p.Ser200Ter variant in KIFBP has been previously reported in two siblings with Goldberg-Shprintzen megacolon syndrome and segregated with disease in this family (PMID: 23427148), but has been identified in 0.007% (9/128934) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs730882150). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. These two affected siblings were homozygotes, which increases the likelihood that the p.Ser200Ter variant is pathogenic (PMID: 23427148). This variant has also been reported in ClinVar (Variation ID: 183145) and has been interpreted as pathogenic by Fulgent Genetics, Eurofins NTD LLC, and OMIM. RT-PCR analysis performed on affected tissue showed significantly reduced mRNA and protein expression versus wild-type (PMID: 23427148). This nonsense variant leads to a premature termination codon at position 200, which is predicted to lead to a truncated or absent protein. Loss of function of the KIFBP gene is an established disease mechanism in Goldberg-Shprintzen megacolon syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Goldberg-Shprintzen megacolon syndrome. ACMG/AMP Criteria applied: PVS1, PS3_Moderate, PM2_Supporting, PM3_Supporting (Richards 2015). - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 02, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease (Drvillon et al., 2013); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32939943, 28277559, 23427148) - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 28, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at